TPLNX
Price
$20.78
Change
+$0.05 (+0.24%)
Updated
Jul 31 closing price
Net Assets
183.26M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

TPLNX vs VSMAX

TPLNX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
TPLNX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TPLNX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. TPLNX (183M). VSMAX pays higher dividends than TPLNX: VSMAX (1.21) vs TPLNX (0.24). TPLNX was incepted earlier than VSMAX: TPLNX (32 years) vs VSMAX (26 years). TPLNX (1.64) is less costly to investors than VSMAX (0.05). TPLNX is a more actively managed with annual turnover of: 56.00 vs. VSMAX (17.00). TPLNX has a lower initial minimum investment than VSMAX: TPLNX (1000) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. TPLNX (9.95). VSMAX return over 5 years is better than : 35.11 vs. TPLNX (-0.08).
TPLNXVSMAXTPLNX / VSMAX
Total Expense Ratio1.500.053,000%
Annual Report Gross Expense Ratio1.640.053,280%
Fund Existence32 years26 years-
Gain YTD14.68014.588101%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets183M189B0%
Annual Yield % from dividends0.241.2120%
Returns for 1 year9.9522.5844%
Returns for 3 years12.2443.4228%
Returns for 5 years-0.0835.11-0%
Returns for 10 years29.93155.9619%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H